Answers are grounded in this paper and cite their sources.
The pharmaceutical industry faces significant cybersecurity challenges, increasing threats to sensitive data, intellectual property, and patient information. Traditional cybersecurity models, including signature-based and threshold-based intrusion detection systems (IDS), often fail to address cyber threats’ dynamic and evolving nature. This paper introduces a novel Artificial Intelligence (AI-driven) cryptographic system designed to enhance cybersecurity in the pharmaceutical sector. The proposed model integrates advanced AI techniques, including reinforcement learning, game theory, and C*-algebra, to optimize resource allocation, improve threat detection, and enhance cryptographic protocols. Through a comprehensive evaluation, the AI model demonstrates superior performance over traditional methods, achieving a detection rate of 97.4%, significantly reducing false positive rates (2.6%) and response time (50ms), and achieving an F1-score of 0.95. Additionally, the AI model’s ability to continuously adapt to emerging cyber threats makes it a future-proof solution for the pharmaceutical industry. The model’s scalability ensures its applicability across various organizational sizes. Future research directions include the integration of blockchain, cloud computing, and post-quantum cryptography to strengthen the system’s resilience further. This paper presents a scalable, adaptive, and efficient solution to address the growing cybersecurity challenges in the pharmaceutical industry, ensuring critical data protection in an increasingly complex threat landscape.
No takes yet. Share an insight, caveat, or question.
Chaganti et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: